Trial NCT01233505

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2011-02543
Secondary IDs: 8604 C010903 CDR0000687938 NCI-2011-02543 P30CA014520 U01CA062491

Last trial update was posted on 2014-04-02

MeSH Interventions

Capecitabine Oxaliplatin Veliparib

MeSH Conditions

Adenocarcinoma Breast Neoplasms Carcinoma, Ovarian Epithelial Colonic Neoplasms Cystadenocarcinoma Cystadenocarcinoma, Mucinous Germinoma Neoplasms Neoplasms, Germ Cell and Embryonal Ovarian Neoplasms Pancreatic Neoplasms Rectal Neoplasms Recurrence Stomach Neoplasms

Other Conditions

Adenocarcinoma of the Pancreas Adenocarcinoma of the Stomach BRCA1 Mutation Carrier BRCA2 Mutation Carrier Ovarian Mucinous Cystadenocarcinoma Recurrent Breast Cancer Recurrent Colon Cancer Recurrent Gastric Cancer Recurrent Ovarian Epithelial Cancer Recurrent Ovarian Germ Cell Tumor Recurrent Pancreatic Cancer Recurrent Rectal Cancer Stage IA Breast Cancer Stage IB Breast Cancer Stage II Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer Stage IV Breast Cancer Stage IV Colon Cancer Stage IV Gastric Cancer Stage IV Ovarian Epithelial Cancer Stage IV Ovarian Germ Cell Tumor Stage IV Pancreatic Cancer Stage IV Rectal Cancer Unspecified Adult Solid Tumor, Protocol Specific

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID